首页> 外国专利> Immunogenic substances which inhibit metastases and malignant tumours - are higher mol. wt. substances contg. or polymers of low. mol. wt. substances which block immune defence mechanism, esp. antiinflammatories

Immunogenic substances which inhibit metastases and malignant tumours - are higher mol. wt. substances contg. or polymers of low. mol. wt. substances which block immune defence mechanism, esp. antiinflammatories

机译:抑制转移和恶性肿瘤的免疫原性物质更高。重量物质续或低聚物。摩尔重量阻止免疫防御机制的物质,尤其是。抗炎药

摘要

Agent having immunoregulatory properties, especially inhibitory activity against in-vivo development of those organisms or cells which are capable of secreting or freeing in vivo "immuno-repulsive substances", especially low molecular weight antiinflammatories, contains active constituents of higher molecular weight, having in their structures several groups respectively derived from low molecular weight immuno-repulsive substances of the type which pathogenic cells or organisms of the type in question are capable of secreting or freeing either in the host organism or in vitro culture medium; the number of these groups being sufficient to give the active constituents a sufficient molecular weight so as to make them immunogenic. Usually the higher molecular weight active constituents are polymers of the "immuno-repulsive substances." "Immuno-repulsive substances" are those cpds. which are capable of blocking the normal immune defence mechanisms of the host. Immunoregulatory substances which reinforce the immune defence mechanism of the host against pathogens. The substances may be used therapeutically to inhibit the proliferation of metastases and malignant tumour cells or to avoid the development of microorganisms or parasites which inhibit the immune defence mechanism of the host. The agent may also be associated with (opt. co-crosslinked) the active constituents of specific vaccines, which are only weakly effective, so as to reinforce their activity. The substances are usually administered parentally, orally or rectally in doses of 5-10 mg/kg. The substances may also be used as reagents e.g. as reference standards in the testing of substances which inhibit malignant tumours, pathogenic microorganisms, parasites.
机译:具有免疫调节特性的试剂,尤其是对那些能够在体内分泌或释放“免疫排斥性物质”的生物体或细胞的体内发育具有抑制活性的试剂,尤其是低分子量抗炎药,含有较高分子量的活性成分,具有它们的结构分别由几种类型的低分子量免疫排斥物质衍生而来的组,其中所述类型的病原细胞或生物体能够在宿主生物体或体外培养基中分泌或释放。这些基团的数目足以使活性成分具有足够的分子量,从而使其具有免疫原性。通常,较高分子量的活性成分是“免疫排斥物质”的聚合物。 “免疫排斥物质”是那些cpds。能够阻断宿主的正常免疫防御机制。增强宿主抵抗病原体免疫防御机制的免疫调节物质。所述物质可在治疗上用于抑制转移和恶性肿瘤细胞的增殖,或避免产生抑制宿主的免疫防御机制的微生物或寄生虫。该试剂还可以与仅弱效的特定疫苗的活性成分结合(优选共交联),以增强其活性。该物质通常以5-10 mg / kg的剂量经胃肠外,口服或直肠给药。该物质也可以用作试剂,例如。作为检测恶性肿瘤,病原微生物,寄生虫的物质的参考标准。

著录项

  • 公开/公告号FR2436605A1

    专利类型

  • 公开/公告日1980-04-18

    原文格式PDF

  • 申请/专利权人 PASTEUR INSTITUT;

    申请/专利号FR19780027264

  • 发明设计人 ROBERT FAUVE;

    申请日1978-09-22

  • 分类号A61K45/05;C07G17/00;G01N33/54;

  • 国家 FR

  • 入库时间 2022-08-22 17:20:56

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号